Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1995-06-07
1999-12-14
Cunningham, Thomas M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241981, 435 693, 514 12, 514 18, 530350, 530395, 530403, 530868, A61K 3539, A61K 3900
Patent
active
060013605
ABSTRACT:
Compositions and methods for the treatment or prevention of insulin dependent diabetes (IDD) are provided. Specifically, glutamic acid decarboxylase (GAD) proteins, and fragments. thereof, can be administered to an animal in order to the reduce the severity of IDD.
REFERENCES:
patent: 4536479 (1985-08-01), Vander-Mallie
patent: 4751181 (1988-06-01), Keene
patent: 5114844 (1992-05-01), Cohen et al.
patent: 5475086 (1995-12-01), Tobin et al.
patent: 5512447 (1996-04-01), Baekkeskov et al.
patent: 5762937 (1998-06-01), Atkinson et al.
Fudenberg, et al., Basic and Clinical Immunology, 3rd Edition, Chapter 17, Lange Med. Pub. 1980.
Connor, et al., 1991 J. Fla. Med. Assoc. 78:739, 1991.
Gammon et al., Nature 342: 183, 1989.
Nihara, et al., Eun. S. Immunol., 26: 1736, 1995.
Lamb, et al., Immunolgy 85: 447, 1995.
McFarland, Science 274: 2037, 1996.
Atkinson, M.A. et al. (1990) "64,000 M.sub.r autoantibodies as predictors of insulin-dependent diabetes" The Lancet 335:1357-1360.
Atkinson, M.A., N.K. Maclaren (1988) "Autoantibodies in Nonobese Diabetic Mice Immunoprecipitate 64,000-M.sub.r Islet Antigen" Diabetes 37(11):1587-1590.
Atkinson, M.A., N.K. Maclaren (1990) "What Causes Diabetes" Scientific American 262(7):62-71.
Baekkeskov, S. et al. (1987) "Antibodies to a 64,000 M.sub.r Human Islet Antigen Precede the Clinical Onset of Insulin-dependent Diabetes" J. Clin. Invest. 79:926-934.
Baekkeskov, S. et al. (1982) "Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins" Nature 298:167-169.
Baekkeskov, S. et al. (1984) "Autoantibodies to a 64-Kilodalton Islet Cell Protein Precede the Onset of Spontaneous Diabetes in the BB Rat" Science 224:1348-1350.
Baekkeskov, S. et al. (1990) "Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase" Nature 347:151-156.
Bottazzo, G.F., R. Lendrum (1976) "Separate Antibodies to Human Pancreatic Glucagon and Somatostatin Cells" The Lancet 873-876.
Bottazzo, G.F. et al. (1974) "Islet-Cell Antibodies in Diabetes Mellitus with Autoimmune Polyendocrine Deficiencies" The Lancet 1279-1282.
Colman, P.G. et al. (1988) "A Prozone Phenomenon Interferes in Islet Cell Antibody Detection: Direct Comparison of Two Methods in Subjects at Risk of Diabetes and in Insulin Dependent Diabetics at Onset" Journal of Autoimmunity 1:109-117.
Geffner, M.E., B.M. Lippe (1987) "The Role of Immunotherapy in Type I Diabetes Mellitus" Western Journal of Medicine 146:337-343.
Gepts, W., J. De May (1978) "Islet Cell Survival Determined by Morphology" Diabetes 27 (Suppl. 1):251-261.
Gerling, I. et al. (1986) "Islet Cell and 64K Autoantibodies are Associated with Plasma AgG in Newly Diagnosed Insulin-Dependent Diabetic Children" The Journal of Immunology 137(12):3782-3785.
Gorsuch, A.N. et al. (1982) "Can Future Type I Diabetes be Predicted? A Study In Families of Affected Children" Diabetes 341:862-866.
Julien, J.-F. et al. (1990) "Rat Brain Glutamic Acid Decarboxylase Sequence Deducted from a Cloned cDNA" Journal of Neurochemistry 54(2):703-705.
Keilacker, H. et al. (1988) "Screening Monoclonal Islet Cell Surface Antibodies (ICSA) by Radioimmunoassay--Detection of Crossreactivity with ICSA from Insulin-Dependent (Type I) Diabetic Patients" Exp. Clin. Endocrinol. 91(1):13-19.
Kobayashi, Y. et al. (1987) "Glutamic Acid Decarboxylase cDNA: Nucleotide Sequence Encoding an Enzymatically Active Fusion Protein" The Journal of Neuroscience 7(9):2768-2772.
Maclaren, N.K. (1988) "Perspectives in Diabetes-How, When, and Why to Predict IDDM" Diabetes 37:1591-1594.
Maron, R. et al. (1983) Autoantibodies to the insulin receptor in juvinile onset insulin-dependent diabetes Nature 303:817-818.
Palmer, J.P. et al. (1983) "Insulin Antibodies in Insulin-Dependent Diabetics before Insulin Treatment" Science 222:1337-1339.
Sakata, S. et al. (1988) "Molecular Recoginition of Human Insulin REceptor by Autoantibodies in a Human Serum" Immunological Investigations 17(3):237-242.
Solimena, M. et al. (1988) "Autoantibodies to Glutamic Acid Decarboxylase in a Patient with Stiff-Man Syndrome, Epilepsy, and Type I Diabetes Mellitus" The New England Journal of Medicine 318(16):1012-1020.
Solimena, M. et al. (1990) "Autoantibodies to Gaba-Ergic Neurons and Pancreatic Beta Cells in Stiff-Man Syndrome" 1555-1560.
Stites, D.P. et al (1980) "The Role of Viruses in Autoimmunity" Basic & Clinical Immunology, pp. 226-227, pp. 654-655.
Winter, W.E. et al. (1984) "Pancreatic Alpha Cell Autoantibodies and Glucagon Response to Arginine" Diabetes 33(5):435-437.
Atkinson Mark A.
Maclaren Noel K.
Cunningham Thomas M.
Lubet Martha
University of Florida
LandOfFree
Method and compositions for early detection and treatment of ins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and compositions for early detection and treatment of ins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and compositions for early detection and treatment of ins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-860489